213 related articles for article (PubMed ID: 32008198)
1. Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study.
de Paiva BR; Esgalhado M; Borges NA; Kemp JA; Alves G; Leite PEC; Macedo R; Cardozo LFMF; de Brito JS; Mafra D
Int Urol Nephrol; 2020 Mar; 52(3):549-555. PubMed ID: 32008198
[TBL] [Abstract][Full Text] [Related]
2. Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial.
Esgalhado M; Kemp JA; Paiva BR; Brito JS; Cardozo LFMF; Azevedo R; Cunha DB; Nakao LS; Mafra D
Food Funct; 2020 Mar; 11(3):2617-2625. PubMed ID: 32159187
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Enriched Resistant Starch Type-2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial.
Kemp JA; Regis de Paiva B; Fragoso Dos Santos H; Emiliano de Jesus H; Craven H; Z Ijaz U; Alvarenga Borges N; G Shiels P; Mafra D
Mol Nutr Food Res; 2021 Oct; 65(19):e2100374. PubMed ID: 34390604
[TBL] [Abstract][Full Text] [Related]
4. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
[TBL] [Abstract][Full Text] [Related]
5. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial.
Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D
J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282
[TBL] [Abstract][Full Text] [Related]
6. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.
Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND
BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.
Snelson M; Kellow NJ; Coughlan MT
Adv Nutr; 2019 Mar; 10(2):303-320. PubMed ID: 30668615
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).
Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D
Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986
[TBL] [Abstract][Full Text] [Related]
10. Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients.
Kemp JA; Dos Santos HF; de Jesus HE; Esgalhado M; de Paiva BR; Azevedo R; Stenvinkel P; Bergman P; Lindholm B; Ribeiro-Alves M; Mafra D
J Am Nutr Assoc; 2022; 41(8):788-795. PubMed ID: 35512757
[TBL] [Abstract][Full Text] [Related]
11. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
Moraes C; Borges NA; Mafra D
Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived melatonin from Puerariae Lobatae Radix-resistant starch supplementation attenuates ischemic stroke injury via a positive microbial co-occurrence pattern.
Lian Z; Xu Y; Wang C; Chen Y; Yuan L; Liu Z; Liu Y; He P; Cai Z; Zhao J
Pharmacol Res; 2023 Apr; 190():106714. PubMed ID: 36863429
[TBL] [Abstract][Full Text] [Related]
13. Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial.
Tayebi Khosroshahi H; Vaziri ND; Abedi B; Asl BH; Ghojazadeh M; Jing W; Vatankhah AM
Hemodial Int; 2018 Oct; 22(4):492-500. PubMed ID: 29532981
[TBL] [Abstract][Full Text] [Related]
14. Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial.
Borges NA; Carmo FL; Stockler-Pinto MB; de Brito JS; Dolenga CJ; Ferreira DC; Nakao LS; Rosado A; Fouque D; Mafra D
J Ren Nutr; 2018 Jan; 28(1):28-36. PubMed ID: 28888762
[TBL] [Abstract][Full Text] [Related]
15. Resistant starch slows the progression of CKD in the 5/6 nephrectomy mouse model.
Karaduta O; Glazko G; Dvanajscak Z; Arthur J; Mackintosh S; Orr L; Rahmatallah Y; Yeruva L; Tackett A; Zybailov B
Physiol Rep; 2020 Oct; 8(19):e14610. PubMed ID: 33038060
[TBL] [Abstract][Full Text] [Related]
16. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
[TBL] [Abstract][Full Text] [Related]
17. Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis.
Jia L; Dong X; Li X; Jia R; Zhang HL
Int J Med Sci; 2021; 18(3):811-820. PubMed ID: 33437217
[No Abstract] [Full Text] [Related]
18. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
McFarlane C; Ramos CI; Johnson DW; Campbell KL
J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
[TBL] [Abstract][Full Text] [Related]
19. Effect of Unripe Banana Flour on Gut-Derived Uremic Toxins in Individuals Undergoing Peritoneal Dialysis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
de Andrade LS; Sardá FAH; Pereira NBF; Teixeira RR; Rodrigues SD; de Lima JD; Dalboni MA; Aoike DT; Nakao LS; Cuppari L
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671166
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
